Root (ROOT) had the highest return in Q1 2024 by a mid-cap US stock, returning 486.2%.

ASSET	QUARTER	% RETURN
Root (ROOT)	Q1 2024	486.18%
Viking Therapeutics (VKTX)	Q1 2024	342.53%
Trump Media & Technology (DJT)	Q1 2024	251.25%
GeneDx (WGS)	Q1 2024	238.15%
WM Technology (MAPSW)	Q1 2024	225%
Arcutis Biotherapeutics (ARQT)	Q1 2024	212.62%
Avidity Biosciences (RNA)	Q1 2024	182.93%
SoundHound AI (SOUN)	Q1 2024	176.53%
Apogee Therapeutics, Inc Common Stock (APGE)	Q1 2024	142.08%
D-Wave Quantum (QBTS)	Q1 2024	131.82%
Sweetgreen (SG)	Q1 2024	127.98%
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS)	Q1 2024	111.16%
Tarsus Pharmaceuticals (TARS)	Q1 2024	81.75%
Rumble (RUM)	Q1 2024	79.56%
Hims Hers Health (HIMS)	Q1 2024	75.8%
Banco Macro SA B ADR (BMA)	Q1 2024	74.75%
CleanSpark (CLSK)	Q1 2024	68.33%
Edgewise Therapeutics (EWTX)	Q1 2024	66.88%
Merus (MRUS)	Q1 2024	66.1%
CAVA (CAVA)	Q1 2024	65.1%
Oscar Health (OSCR)	Q1 2024	64.67%
Nuscale Power (SMR)	Q1 2024	63.89%
Powell Industries (POWL)	Q1 2024	63.73%
PureCycle Technologies (PCTTW)	Q1 2024	62.28%
BBVA Banco Frances SA ADR (BBAR)	Q1 2024	59.72%

Mid-cap stocks are treated as having a market cap between $2B and $10B.